The injection is well tolerated by most people, and some do not feel it
FDA Mounjaro NDA 215866 / Zepbound NDA 217806 reviews
Recalls & Warnings September 12, 2012 Distribution of Weight Loss Product Containing DMAA Should Be Stopped Immediately, Warns FDA On August 28, 2012, the FDA issued a warning letter to Regeneca stating that the company's RegeneSlim, which was promoted as a dietary supplement for weight loss, is adulterated with dimethylamylamine (DMAA) and that failure to immediately cease distribution of this product could result in FDA
Injections may be given to people who have malabsorption issues due to disorders such as Crohn's disease, atrophic gastritis, chronic pancreatitis, and intestinal bacterial overgrowth
We keep a medical record of your treatment